Behavioral Health Business June 30, 2022
Opioid treatment programs (OTP) can continue to virtually prescribe buprenorphine to new and existing patients after the public health emergency ends.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced June 28 that OTPs can continue prescribing through telemedicine without requiring patients to come in for an in-person medical visit for up to a year.
The new virtual prescribing flexibility excludes methadone; the in-person medical evaluation remains in effect for that medication, according to an announcement from SAMHSA.
In April 2020, SAMHSA exempted OTPs from the requirement to perform an in-person medical evaluation if telehealth provides adequate supervision. The exemption came in response to the federal PHE for the coronavirus.
The PHE, which has been extended several...